medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
58条
与
Metastatic
有关的结果
German S3 Guideline for Renal Cell Carcinoma : Presentation and Discussion of Essential Aspects for the Radiation Oncologist
2018年 发布于
Strahlenther Onkol
194卷 第1期
所属人体系统:
泌尿
|
肾癌
无
Purpose: We Aim to Introduce and Discuss the Statements and Recommendations of the German S3 Guideline on Renal Cell Cancer for Daily Practice of Radiation Oncologists
Methods: This Report Comprises Indication
Treatment Decision
Dose Prescription and Current Literature Including Treatment of Oligometastatic Disease
Results: According to Different Stages of the Disease and the Structure of the Guideline We Focus on Five Treatment Situations and Recommendations for Decision Making: (1) Neo-/adjuvant Treatment Before Or after Nephrectomy: No Indication for Radiotherapy (2) Small Renal Mass: Stereotactic Ablative Radiotherapy Is Currently Seen as Experimental Option due to Small Patient Numbers Reported in the Literature However
Local Tumor Control Achieved by SBRT Appears Favourable with >90% at 2 Years (3) Oligometastasis: Radiation Treatment with Higher Local Doses Or Stereotactic Treatment Is Possible after Interdisciplinary Discussion Indications for Palliative (4) and Symptomatic Treatment (5) Are Not Different Compared to Other Tumor Entities
Conclusion: Currently
There Is No Evidence-based Indication for Radiation Treatment in the Primary Setting (adjuvant/neoadjuvant Or Definitive) of Renal Cell Cancer in the Future Stereotactic Radiotherapy Should Have a Stronger Role in the Treatment of Medically Inoperable Patients with Primary Renal Cell Cancer and Especially in the Setting of Oligometastasis
指南简介
原文链接
Elderly Patients with Metastatic Renal Cell Carcinoma: Position Paper from the International Society of Geriatric Oncology
2018年 发布于
Lancet Oncol
19卷 第6期
所属人体系统:
泌尿
|
肾癌
International Society of Geriatric Oncology
Elderly Patients
Metastatic
Renal Cell Carcinoma
指南简介
原文链接
Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
2018年 发布于
Eur Urol
74卷 第6期
所属人体系统:
泌尿
|
肾癌
European Association of Urology
Cytoreductive Nephrectomy
EAU Guidelines
Metastatic
Renal Cell Cancer
Sunitinib
指南简介
原文链接
SEOM Clinical Guideline for the Management of Malignant Melanoma (2017)
2018年 发布于
Clin Transl Oncol
20卷 第1期
所属人体系统:
其他
|
黑色素瘤
Spanish Society of Medical Oncology
Melanoma
Metastatic
Adjuvant
Immunotherapy
B-RAF
指南简介
原文链接
4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
2018年 发布于
Ann Oncol
29卷 第8期
所属人体系统:
生殖
|
乳腺肿瘤
ESO-European Society for Medical Oncology
Advanced Breast Cancer
metastatic Breast Cancer
指南简介
原文链接
Consensus Statements on the Management of Metastatic Prostate Cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology
2018年 发布于
BJU Int
121卷 第5期
所属人体系统:
生殖
|
前列腺肿瘤
Hong Kong Urological Association and Hong Kong Society of Uro-Oncology
ProstateCancer
Castration-naïve Prostate Cancer
Castration-resistant Prostate Cancer
Consensus
Metastatic
Prostate Cancer
指南简介
原文链接
Use of Modern Imaging Methods to Facilitate Trials of Metastasis-directed Therapy for Oligometastatic Disease in Prostate Cancer: a Consensus Recommendation from the EORTC Imaging Group
2018年 发布于
Lancet Oncol
19卷 第10期
所属人体系统:
生殖
|
前列腺肿瘤
EORTC Imaging Group
Oligometastatic Disease
prostate Cancer
指南简介
原文链接
Testosterone Suppression in the Treatment of Recurrent Or Metastatic Prostate Cancer - a Canadian Consensus Statement
2018年 发布于
Can Urol Assoc J
12卷 第2期
所属人体系统:
生殖
|
前列腺肿瘤
无
Testosterone Suppression
Androgen-deprivation Therapy (ADT)
Metastatic
Prostate Cancer
指南简介
原文链接
Management of Patients with Advanced Prostate Cancer: the Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [Figure Presented]
2018年 发布于
Eur Urol
73卷 第2期
所属人体系统:
生殖
|
前列腺肿瘤
The Advanced Prostate Cancer Consensus Conference (APCCC) 2017
Advanced and High-risk Localized Prostate Cancer
Castration-naive and Castration-resistant Prostate Cancer
Consensus
Oligometastatic Prostate Cancer
Therapeutics
指南简介
原文链接
Clinical Management of Spinal Metastases-The Dutch National Guideline
2018年 发布于
Eur J Cancer
104:81-90.卷 第期
所属人体系统:
运动
|
骨肿瘤
无
Diagnostics
Guideline
Metastatic
Epidural Spinal Cord Compression
Spinal Metastasis
Treatment
指南简介
原文链接
Consensus Statement on Essential Patient Characteristics in Systemic Treatment Trials for Metastatic Colorectal Cancer: Supported by the ARCAD Group
2018年 发布于
Eur J Cancer
100卷 第期
所属人体系统:
消化
|
结直肠肿瘤
ARCAD Group
Clinical Trials
Colorectal Cancer
Delphi Survey
Metastatic
Disease
Patient Characteristics
Prognosis
Stratification
指南简介
原文链接
The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: an Endorsement of a Canadian Consensus Statement
2018年
所属人体系统:
消化
|
结直肠肿瘤
McMaster University
Colorectal Neoplasms
Primary Tumour Location
Biologics
Unresectable
Metastatic
treatment
Consensus Statement
指南简介
原文链接
Consensus on Management of Metastatic Colorectal Cancer in Central America and the Caribbean: San José, Costa Rica, August 2016
2018年 发布于
ESMO Open
15卷 第3期
所属人体系统:
消化
|
结直肠肿瘤
无
Colorectal Cancer Management
Consensus
Metastatic
Colorectal Cancer
Wild Type
指南简介
原文链接
Pan-Asian Adapted Clinical Practice Guidelines for the Management of Patients with Metastatic Non-small-cell Lung Cancer: a CSCO-ESMO Initiative Endorsed by JSMO, KSMO, MOS, SSO and TOS
2019年 发布于
Ann Oncol
30卷 第2期
所属人体系统:
呼吸
|
肺癌
European Society for Medical Oncology
Chinese Society of Clinical Oncology
Oncological Societies of Japan (JSMO)
Korea (KSMO)
Malaysia (MOS)
Singapore (SSO) and Taiwan (TOS)
Pan-Asian
Consensus
Guidelines
Metastatic
NSCLC.
指南简介
原文链接
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
2019年 发布于
J Thorac Oncol
14卷 第12期
所属人体系统:
呼吸
|
肺癌
无
Consensus Definition
Non–small Cell Lung Cancer
Oligometastatic Disease
Staging
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
生殖
|
输卵管癌
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When
Metastatic
Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
生殖
|
输卵管癌
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When
Metastatic
Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Short Text of the French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa
2019年 发布于
Eur J Obstet Gynecol Reprod Biol
236卷 第_期
所属人体系统:
生殖
|
卵巢肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (Grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (Grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). Adjuvant Chemotherapy by Carboplatin and Paclitaxel Is Recommended for All High-grade Ovarian and Tubal Cancers (FIGO Stages I-IIA) (grade A). for FIGO Stage III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (Grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancers (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When
Metastatic
Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B). after Primary Surgery Is Complete
6 Cycles of Intravenous Chemotherapy (grade A) Are Recommended
Or a Discussion with the Patient About Intraperitoneal Chemotherapy
According to Her Risk-benefit Ratio. after Complete Interval Surgery for FIGO Stage III Disease
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Can Be Proposed
in Accordance with the Modalities of the OV-HIPEC Trial (grade B). in Cases of Postoperative Tumor Residue Or in FIGO Stage IV Tumors
Chemotherapy Associated with Bevacizumab Is Recommended (grade A).
指南简介
原文链接
Management of Epithelial Cancer of the Ovary, Fallopian Tube, and Primary Peritoneum. Long Text of the Joint French Clinical Practice Guidelines Issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and Endorsed by INCa. Part 1: Diagnostic Exploration and Staging, Surgery, Perioperative Care, and Pathology
2019年 发布于
Journal of Gynecology Obstetrics and Human Reproduction
48卷 第6期
所属人体系统:
生殖
|
卵巢肿瘤
FRANçais De Recherche En Chirurgie Oncologique Et GYNécologique (FRANCOGYN)
Le Collège National Des Gynécologues Et Obstétriciens Français (CNGOF)
La Société Française D’oncologie Gynécologique (SFOG) Et Le Groupe D’investigateurs National Des Études Des Cancers Ovariens Et Du Sein (GINECO-ARCAGY) Et De L’institut National Du Cancer (INCa)
An MRI Is Recommended for an Ovarian Mass That Is Indeterminate on Ultrasound. the ROMA Score (combining CA125 and HE4) Can Also Be Calculated (grade A). in Presumed Early-stage Ovarian Or Tubal Cancers
the Following Procedures Should Be Performed: an Omentectomy (at a Minimum
Infracolic)
an Appendectomy
Multiple Peritoneal Biopsies
Peritoneal Cytology (grade C)
and Pelvic and Para-aortic Lymphadenectomies (grade B) for All Histologic Types
Except the Expansile Mucinous Subtypes
for Which Lymphadenectomies Can Be Omitted (grade C). Minimally Invasive Surgery Is Recommended for Early-stage Ovarian Cancer
When There Is No Risk of Tumor Rupture (grade B). for FIGO Stages III Or IV Ovarian
Tubal
and Primary Peritoneal Cancers
a Contrast-enhanced Computed Tomography (CT) Scan of the Thorax/abdomen/pelvis Is Recommended (grade B)
as Well as Laparoscopic Exploration to Take Multiple Biopsies (grade A) and a Carcinomatosis Score (Fagotti Score at a Minimum) (grade C) to Assess the Possibility of Complete Surgery (i.e.
Leaving No Macroscopic Tumor Residue). Complete Surgery by a Midline Laparotomy Is Recommended for Advanced Ovarian
Tubal
Or Primary Peritoneal Cancer (grade B). for Advanced Cancers
Para-aortic and Pelvic Lymphadenectomies Are Recommended When
Metastatic
Adenopathy Is Clinically Or Radiologically Suspected (grade B). When Adenopathy Is Not Suspected and When Complete Peritoneal Surgery Is Performed as the Initial Surgery for Advanced Cancer
the Lymphadenectomies Can Be Omitted Because They Do Not Modify Either the Medical Treatment Or Overall Survival (grade B). Primary Surgery (before Other Treatment) Is Recommended Whenever It Appears Possible to Leave No Tumor Residue (grade B).
指南简介
原文链接
Diagnosis of Metastasis in Castration-resistant Prostate Cancer Patients: Decision Algorithm in Imaging Tests
2019年 发布于
Actas Urol Esp (Engl Ed)
43卷 第2期
所属人体系统:
生殖
|
前列腺肿瘤
Andalusian Association of Urology
Cáncer De Próstata
Cáncer De Próstata Resistente a La Castración Metastásico (CPRCm)
Diagnostic Imaging Tests
Metastatic
Castration-resistant Prostate Cancer (mCRPC)
Prostate Cancer
Pruebas De Diagnóstico Por La Imagen.
指南简介
原文链接
首页
1
2
3
下一页
尾页
共58条,每页显示
20条
50条
100条
跳转至第
页
确定